Biosimilars Drug Research Packaging 
Agency IQ
AUGUST 2, 2024
Another legislative area that will also likely receive more attention will be the pharma reform package , since the two Parliament rapporteurs to lead the package negotiations were recently appointed.
Agency IQ
JUNE 9, 2023
Here, we’re starting some deeper analysis of aspects of the proposal package with a look at the impact of orphan drug provisions, seeing what impact the new provisions and the surrounding uncertainty might have on innovation. Reduced market exclusivity would foster generic and biosimilar competition through earlier market access.
Expert insights. Personalized for you.
40 
Let's personalize your content